Company · CIK 0001401667 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
PUMA BIOTECHNOLOGY, INC. · PBYI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 16, 9:13 pm EDT | Troy Edward WilsonDirector | 5,000 | $9.10 | $45,500 | 54,750 | −8.37% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 9:06 pm EDT | Alessandra CesanoDirector | 62,150 | $9.12 | $566,994 | 56,700 | −52.3% | 10b5-1 |
| Sep 14, 2026 MForm 4 → | Sep 16, 9:06 pm EDT | Alessandra CesanoDirector | 50,000 | $2.93 | $146,500 | 118,850 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 8:21 pm EDT | Alan H AuerbachPresident and CEO, Director, 10% Owner | 44,058 | $8.26 | $364,051 | 7,261,671 | −0.60% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 8:19 pm EDT | Douglas M HuntSee Remarks | 8,460 | $8.26 | $69,905 | 196,841 | −4.12% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 8:18 pm EDT | Maximo F NouguesChief Financial Officer | 9,386 | $8.26 | $77,557 | 230,637 | −3.91% | 10b5-1 |
| Jun 12, 2026 SForm 4 → | Jun 15, 8:16 pm EDT | Troy Edward WilsonDirector | 10,800 | $7.20 | $77,748 | 59,750 | −15.3% | 10b5-1 |
| Jun 12, 2026 SForm 4 → | Jun 15, 8:14 pm EDT | Brian M StuglikDirector | 8,100 | $7.20 | $58,311 | 113,858 | −6.64% | 10b5-1 |
| Jun 12, 2026 SForm 4 → | Jun 15, 8:13 pm EDT | Adrian SenderowiczDirector | 27,000 | $7.20 | $194,311 | 27,000 | −50.0% | 10b5-1 |
| Jun 12, 2026 SForm 4 → | Jun 15, 8:10 pm EDT | Jay M MoyesDirector | 22,000 | $7.22 | $158,796 | 58,322 | −27.4% | 10b5-1 |
| Jun 12, 2026 SForm 4 → | Jun 15, 8:09 pm EDT | Allison DorvalDirector | 11,610 | $7.20 | $83,579 | 90,780 | −11.3% | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 8:16 pm EDT | Troy Edward WilsonDirector | 27,000 | — | — | 70,550 | — | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 8:14 pm EDT | Brian M StuglikDirector | 27,000 | — | — | 121,958 | — | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 8:13 pm EDT | Adrian SenderowiczDirector | 27,000 | — | — | 54,000 | — | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 8:12 pm EDT | Michael Patrick MillerDirector | 27,000 | — | — | 81,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 8:10 pm EDT | Jay M MoyesDirector | 27,000 | — | — | 80,322 | — | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 8:09 pm EDT | Allison DorvalDirector | 27,000 | — | — | 102,390 | — | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 8:07 pm EDT | Alessandra CesanoDirector | 27,000 | — | — | 68,850 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 MForm 4 → | Sep 16, 9:06 pm EDT | Alessandra CesanoDirector | 50,000 | — | — | 50,000 | — | 10b5-1 |